Kathryn Kersey
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Gastrointestinal motility and disorders
Most-Cited Works
- → Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials(2020)447 cited
- → Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials(2019)260 cited
- → The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection(2016)195 cited
- → Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry(2014)164 cited
- → Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia(2010)154 cited
- → Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4(2015)145 cited
- → A preliminary study of aquatic insect communities and leaf decomposition in acid streams near Dorset, Ontario(1985)120 cited
- → Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection(2016)115 cited
- → Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11(2018)111 cited
- → Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study(2010)109 cited